- Citations, last 5 years
- 356.5k
- Works, last 5 years
- 25.4k
- h-index
- 1,797
- Scientists listed
- 655
- Grants since 2016
- 3 144
Grants received
2015–2020 · research · R01
Validating the eCyPA/CD147 signaling complex for myeloma therapy
Ruben D Carrasco · Dana-Farber Cancer Institute · funded by National Institutes of Health
2015–2020 · career development · K08
Targeting FAK and integrin signaling in preclinical models of Ewing sarcoma
Brian Crompton · Dana-Farber Cancer Institute · funded by National Institutes of Health
2015–2026 · research · R01
Evolution of gliomas during treatment and resistance
Rameen Beroukhim · Dana-Farber Cancer Institute · funded by National Institutes of Health
2015–2020 · career development · K08
Epigenetic mechanisms of drug resistance in T-cell acute lymphoblastic leukemia
Birgit Knoechel · Dana-Farber Cancer Institute · funded by National Institutes of Health
2015–2020 · research · R01
Development of covalent PIP4K2 inhibitors for the treatment of p53 deficient lung tumors
Nathanael Schiander Gray · Dana-Farber Cancer Institute · funded by National Institutes of Health
2015–2021 · research · R01
Identifying the roles of DNA rewinding enzymes on maintaining genome stability
Brendan D Price · Dana-Farber Cancer Institute · funded by National Institutes of Health
2015–2021 · cooperative agreement · U24
Quantitative Radiomics System Decoding the Tumor Phenotype
Hugo Aerts · Dana-Farber Cancer Institute · funded by National Institutes of Health
2015–2020 · grant · BCRP
Therapeutic Targeting of Nonmalignant Accessory Cells in Bone Metastases of Hormone-Resistant ER-Positive Breast Cancer
Constantine Mitsiades · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2015–2020 · research · R01
The function of cyclin C in tumorigenesis
Peter Sicinski · Dana-Farber Cancer Institute · funded by National Institutes of Health
2015–2020 · research · R01
Identifying the roles of DNA rewinding enzymes on maintaining genome stability
Brendan D Price · Dana-Farber Cancer Institute · funded by National Institutes of Health
2015–2020 · research · R01
Novel Roles for Oncogenic SOX2 in Esophageal Squamous Cell Carcinoma
Adam Joel Bass · Dana-Farber Cancer Institute · funded by National Institutes of Health
2015–2022 · research · R35
Dissecting and Targeting Deregulated Mitochondrial Apoptosis in Human Cancer
Loren David Walensky · Dana-Farber Cancer Institute · funded by National Institutes of Health
2015–2021 · research · R01
Studies of IGHV Germline Gene Polymorphism, Utilization & Shifting for Seasonal Influenza Vaccine Induced Broadly Neutralizing Antibody Responses
Wayne A. Marasco · Dana-Farber Cancer Institute · funded by National Institutes of Health
2015–2022 · research · R35
Dissecting and Targeting Deregulated Mitochondrial Apoptosis in Human Cancer
Loren David Walensky · Dana-Farber Cancer Institute · funded by National Institutes of Health
2015–2025 · research · R01
Discovery and optimization of novel mutant-selective allosteric inhibitors of EGFR T790M
Michael J Eck · Dana-Farber Cancer Institute · funded by National Institutes of Health
2015–2029 · research · R35
Targeting intratumor heterogeneity in breast cancer
Kornelia Polyak · Dana-Farber Cancer Institute · funded by National Institutes of Health
2015–2028 · research · R35
Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery
Matthew L. Meyerson · Dana-Farber Cancer Institute · funded by National Institutes of Health
2015–2026 · research · R01
Evolution of gliomas during treatment and resistance
Rameen Beroukhim · Dana-Farber Cancer Institute · funded by National Institutes of Health
2015–2028 · research · R35
Dissecting and Targeting Deregulated Mitochondrial Apoptosis in Human Cancer
Loren David Walensky · Dana-Farber Cancer Institute · funded by National Institutes of Health
2015–2021 · cooperative agreement · U54
Core 1: The Single Cell Profiling Core Facility
Rong Fan · Dana-Farber Cancer Institute · funded by National Institutes of Health
2015–2021 · cooperative agreement · U54
Project 1: Clonal Dynamics Guiding Curative Therapies for Acute Myeloid Leukemia
David T Scadden · Dana-Farber Cancer Institute · funded by National Institutes of Health
2015–2021 · cooperative agreement · U54
Education & Outreach Unit
Franziska Michor · Dana-Farber Cancer Institute · funded by National Institutes of Health
2015–2021 · cooperative agreement · U54
Administrative Core
Franziska Michor · Dana-Farber Cancer Institute · funded by National Institutes of Health
2015–2021 · cooperative agreement · U54
Project 2: Molecular and Clinical Inputs Affecting Optimization of Glioma Therapy
Eric C. Holland · Dana-Farber Cancer Institute · funded by National Institutes of Health
2015–2021 · cooperative agreement · U54
Project 3: Single Cell Measures of Intratumor Diversity for Optimal Breast Cancer Therapy
Kornelia Polyak · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2024 · research · R25
Workshop on Methods in Supportive Oncology Research
William F Pirl · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2025 · research · R01
Metabolic and epigenetic dependencies in melanomas during metastasis and targeted-drug resistance
Pere Puigserver · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2020 · cooperative agreement · UM1
Dana-Farber/Harvard Cancer Center ET-CTN with Phase I Emphasis
Keith T Flaherty · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2020 · research · R01
Systems Biology Analysis of Human Erythropoiesis
Stuart H Orkin · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2024 · research · R25
Workshop on Methods in Supportive Oncology Research
William F Pirl · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2025 · cooperative agreement · U10
ECOG-ACRIN Network Group Statistics and Data Management Center
Constantine A. Gatsonis · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2025 · cooperative agreement · U10
ECOG-ACRIN Network Group Statistics and Data Management Center
Constantine A. Gatsonis · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2020 · research · R01
A high efficiency imager for real-time lung cancer monitoring during radiotherapy
Ross I. Berbeco · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2025 · cooperative agreement · U10
ECOG-ACRIN Network Group Statistics and Data Management Center
Constantine A. Gatsonis · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2025 · research · R01
Metabolic and epigenetic dependencies in melanomas during metastasis and targeted-drug resistance
Pere Puigserver · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2024 · research · R25
Workshop on Methods in Supportive Oncology Research
William F Pirl · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2024 · cooperative agreement · U01
Anatomic and functional characterization of the intestinal crypt-villus niche
Ramesh A Shivdasani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2025 · cooperative agreement · U10
ECOG-ACRIN Network Group Statistics and Data Management Center
Constantine A. Gatsonis · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2025 · research · R01
Metabolic and epigenetic dependencies in melanomas during metastasis and targeted-drug resistance
Pere Puigserver · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2026 · cooperative agreement · UM1
Dana-Farber/Harvard Cancer Center Experimental Therapeutics Clinical Trials Network Site (DF/HCC ETCTN Site)
Keith T Flaherty · Dana-Farber Cancer Institute · funded by National Institutes of Health
